[1]
N. Bradt, F. Olbrechts, P. Alexander, and A. Salembier, “A Dasatinib-Induced Chylothorax Persisting After the Discontinuation of Dasatinib”, EJCRIM, vol. 9, no. 10, Oct. 2022.